Evaxion Biotech A/S

Denmark

 
Total IP 44
Total IP Rank # 31,538
IP Activity Score 2.5/5.0    46
IP Activity Rank # 15,965
Stock Symbol EVAX (nasdaq)
ISIN US29970R1059
Market Cap. 13.30M  (USD)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

25 1
8 0
9 1
0
 
Last Patent 2024 - Vaccines targeting neisseria gon...
First Patent 2012 - Staphylococcus aureus
Last Trademark 2022 - EVAXION
First Trademark 2022 - EVAXION

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa. Disclosed are im...
2023 Invention Peptides derived from acinetobacter baumannii and their use in vaccination. The present inventio...
Invention Process for production of synthetic circular dna. The disclosure provides a novel process for pro...
Invention Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus. The present inven...
Invention Vaccines targeting pseudomonas aeruginosa. Immunogenic proteins from Pseudomonas aeruginosa as w...
2022 Invention Personalized cancer therapy targeting normally non-expressed sequences. Provided is a method for ...
Invention Chimeric proteins for inducing immunity towards infection with s. aureus. Disclosed is chimeric ...
Invention Method for predicting response to cancer immunotherapy. The present invention relates to method f...
Invention Vaccines targeting neisseria gonorrhoeae. Proteins, protein fragments, nucleic acids and vectors...
Invention Vaccines targeting neisseria gonorrhoeae. The present invention relates to proteins, protein frag...
Invention Vaccination targeting intracellular pathogens. Provided are novel fusion polypeptides comprising ...
Invention Staphylococcal protein variants and truncates. The present application discloses novel polypeptid...
G/S Pharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine fo...
G/S Pharmaceuticals and medical preparations; medicine for treatment of cancer; pharmaceuticals prep...
2021 Invention Pseudomonas aeruginosa. Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or tran...
Invention Process for preparation of neopepitope-containing vaccine agents. The present invention presents...
Invention Process for preparation of neopepitope-containing vaccine agents. The present invention presents ...
Invention Apc targeting units for immunotherapy. Immune therapy and vaccines, such as cancer immunotherapy...
Invention Apc targeting units for immunotherapy. The present invention relates to immune therapy and vaccin...
Invention Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus. Disclosed are nov...
Invention Neoepitope immunotherapy with apc targeting unit. The present invention relates to cancer therap...
Invention Neoepitope immunotherapy with apc targeting unit. The present invention relates to cancer therapy...
2020 Invention Nucleic acid vaccination using neo-epitope encoding constructs. The disclosure provides novel mea...
Invention Method for identifying t-cell epitopes. A method for T-cell epitope prediction where quantitativ...
Invention Staphylococcus aureus. S. aureus infections. Also disclosed are nucleic acids encoding the protei...
Invention Nucleic acid vaccination using neo-epitope encoding constructs. Compositions and methods for DNA...
Invention Nucleic acid vaccination using neo-epitope encoding constructs. The disclosure provides means and...
Invention Acinetobacter baumannii and their use in vaccination. Acinetobacter baumanii, nucleic acids encod...
Invention Vaccines targeting h. influenzae. Immunogenic proteins from nontypable Haemophilus influenzae as...
Invention Vaccines targeting neoepitopes. The present invention provides methods of vaccination utilising a...
2019 Invention Staphylococcus aureus. Staphylococcus aureus as well as therapeutic and diagnostic uses of the pr...
2017 Invention S. aureus. S. aureus infection. Also disclosed are compositions, methods of treatment and prophyl...
2016 Invention Klebsiella pneumoniae. Klebsiella pneumonia as well as therapeutic and diagnostic uses of the pro...
2015 Invention Staphylococcus aureus . S. aureus infections. Also disclosed are nucleic acids encoding the prote...
2012 Invention Staphylococcus aureus . S. aureus infections. Also disclosed are nucleic acid encoding the protei...